NCT05784441
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05784441
Title A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ISR | GBR | AUS

Facility Status City State Zip Country Details
University of Iowa Hospital Iowa City Iowa 52242 United States Details
University of Kentucky Lexington Kentucky 40506 United States Details
Mayo Clinic Rochester Rochester Minnesota 55905 United States Details
Rutgers University New Brunswick New Jersey 08901 United States Details
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Royal Prince Alfred Hospital Camperdown 2050 Australia Details
Monash Medical Centre Clayton 3168 Australia Details
Austin Hospital Heidelberg 3084 Australia Details
Royal Brisbane and Women's Hospital Herston 4029 Australia Details
Westmead Hospital Westmead 2145 Australia Details
Hadassah Medical Center Jerusalem 9112001 Israel Details
Sheba Medical Center Ramat Gan 5266202 Israel Details
University College London Hospitals London NW1 2BU United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field